Rivogenlecleucel Active Not Recruiting Phase 1 Trials for Hematological Malignancy Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Active Not Recruiting | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03459170 | Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant |